Wall Street analyst estimates for Exponent, Inc. (EXPO): consensus price target and buy/hold/sell recommendations.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 6 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 8 |
| Avg rating (−2 sell to +2 buy) | 0.75 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-10-29 | $0.64 | $0.60 | +7.4% |
| 2026-07-30 | $0.60 | $0.55 | +9.3% |
| 2026-04-30 | $0.59 | $0.56 | +5.4% |
| 2026-02-05 | $0.49 | $0.47 | +4.3% |
| 2025-10-30 | $0.55 | $0.50 | +10.0% |
| 2025-07-31 | $0.52 | $0.48 | +8.3% |
| 2025-05-01 | $0.52 | $0.48 | +8.3% |
| 2025-02-06 | $0.46 | $0.40 | +15.0% |
Valuation Ratios
| P/E Ratio | 34.59 |
| Price / Book | 12.55 |
| EV / EBITDA | 23.96 |
| Dividend Yield | 1.53% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2020 | 2021 | 2021 | 2022 | 2023 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $315.1M | $347.8M | $379.5M | $417.2M | $399.9M | $466.3M | $513.3M | $536.8M | $558.5M | $582.0M |
| Cost of Revenue | $15.9M | $18.1M | $24.9M | $25.8M | $303.8M | $342.1M | $348.8M | $401.0M | $416.2M | $436.7M |
| Gross Profit | $299.2M | $329.7M | $354.6M | $391.4M | $96.1M | $124.2M | $164.5M | $135.8M | $142.3M | $145.3M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $208.9M | $228.1M | $232.6M | $272.7M | $262.9M | $293.3M | $287.9M | $24.4M | $22.7M | $25.5M |
| Operating Expenses | $253.2M | $275.7M | $288.1M | $306.3M | $12.9M | $15.3M | $23.7M | $24.4M | $22.7M | $25.5M |
| Operating Income | $61.9M | $72.1M | $91.5M | $85.1M | $83.2M | $108.9M | $140.8M | $111.3M | $119.6M | $119.8M |
| EBITDA | $68.0M | $78.3M | $97.7M | $91.9M | $90.1M | $132.3M | $139.3M | $144.8M | $157.1M | $157.4M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-tax Income | $69.1M | $82.5M | $93.3M | $104.2M | $96.9M | $125.8M | $132.2M | $135.9M | $147.4M | $147.3M |
| Income Tax | $21.6M | $41.2M | $21.1M | $21.7M | $14.4M | $24.6M | $29.9M | $35.6M | $38.4M | $41.3M |
| Net Income | $47.5M | $41.3M | $72.3M | $82.5M | $82.6M | $101.2M | $102.3M | $100.3M | $109.0M | $106.0M |
| EPS | $0.90 | $0.78 | $1.37 | $1.57 | $1.58 | $1.92 | $1.98 | $1.96 | $2.13 | $2.08 |
| EPS (Diluted) | $0.87 | $0.77 | $1.33 | $1.53 | $1.55 | $1.90 | $1.96 | $1.94 | $2.11 | $2.07 |
| Shares Outstanding (Diluted) | 54.3 M | 54.0 M | 54.2 M | 53.9 M | 53.3 M | 53.3 M | 52.3 M | 51.6 M | 51.6 M | 51.2 M |
Price
| Price | $80.26 (closing price, October 30, 2026) |
| Market Cap | $3.8B |
| Exchange | NASDAQ |
| Country | US |
Related companies: TTEK · LGN · MYRG · HURN · FLR · FCN · KBR
Explore sector: Industrials · Engineering & Construction
More sections of EXPO: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks